Our mission isto be steadfast andcommitted to outlierentrepreneurs.
We are a full lifecycle investor and write tickets in the range of $500K to $20M and from seed to growth stages.
Our JourneySince 2019
Assets Under Management
Sectors Invested In
Portfolio Public Listings
AbCellera focuses on the discovery and development process of antibody drugs, the largest and fastest growing class of successful biologic therapeutics.
First Check: Series A | March 2020
Alaanpay is simplifying B2B payments in the Middle East by digitizing the flow of money.
First Check: Seed | August 2021
Alloy Therapeutics is empowering the global scientific community by being a cheaper and easier way for scientists to build their biotech company on the Alloy platform.
First Check: Series B | May 2020
Angiex is working on using antibody drug conjugates to cure cancer.
First Check: Series A | October 2019
Atai is a Nasdaq listed clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. We also invested early in Nasdaq listed Compass Pathways, a subsidiary of ATAI, which is developing psilocybin therapy to help people with treatment-resistant depression.
First Check: Series C | October 2020
Bamba is building the universal B2B fintech platform for businesses in Africa.
First Check: Seed | March 2022
Bound is building a self-service digital platform that provides forex risk management products to CFOs around the globe.
First Check: Seed | June 2022
Peptilogics is a next-generation computational drug discovery and development company for the peptide drug class.
First Check: Seed | June 2019
Razor is building the next-gen consumer online conglomerate by aggregating small ecommerce shops first.
First Check: Seed | August 2020
Velocity is a revenue-based financing platform for online eCommerce businesses.
First Check: Seed | February 2020
Music Catalog Buyer Duetti Closes $90 Million Funding Round
Duetti, a company that launched last May and buys the rights to songs from independent artists, has raised $90 million to build its staff and do more deals.
SmithRx Closes $60M in Series C Funding Led by Venrock
SmithRx closed a Series C funding round led by Venrock to continue delivering improved pharmacy benefits and reduced prescription costs.
Transmutex raises $23M to recycle nuclear waste
Nuclear engineering startup Transmutex has raised $23.2 million to produce energy and nuclear fuel from radioactive waste.
CNS disorder biotech Alto Neuroscience sets terms for $100 million IPO
Alto Neuroscience, a Phase 2 biotech developing biomarker-focused therapies for depression and schizophrenia, announced terms for its IPO on Monday.
CNS disorder biotech Alto Neuroscience files for a $100 million IPO
Alto Neuroscience, a Phase 2 biotech developing biomarker-focused therapies for depression and schizophrenia, filed on Friday with the SEC to raise up to $100 million in an initial public offering.
AbbVie and Umoja Biopharma Announce Strategic Collaboration to Develop Novel In-Situ CAR-T Cell Therapies
AbbVie (NYSE: ABBV), and Umoja Biopharma (Umoja), an early clinical-stage biotechnology company, today announced two exclusive option and license agreements to develop multiple in-situ generated CAR-T cell therapy candidates in oncology using Umoja's proprietary VivoVecTM platform.
Thiel-Backed Psychedelic Firm Atai to Buy Stake in Beckley
Atai Life Sciences NV agreed to acquire a stake in smaller rival Beckley Psytech to expand its portfolio of drug candidates for the treatment of mental health conditions.
Alto Neuroscience Announces Positive Results from Phase 2 Study of ALTO-300 in Major Depressive Disorder
Treatment with ALTO-300 led to a significantly greater improvement in depression symptoms in a biomarker-characterized patient population.
Alto Neuroscience Closes $45 Million in Oversubscribed Series C Financing
Alto Neuroscience today announced an oversubscribed $45 million Series C financing. The round was led by InVivium Capital, with participation from additional new investors Franklin Templeton, Point72, Eli Lilly and Company, and Alexandria Venture Investments.
Angiex Announces FDA Clearance of IND Application for AGX101
Angiex announces FDA clearance of IND application for AGX101, a novel, first-in-class TM4SF1-directed antibody-drug conjugate for the treatment of solid cancers.
Bionomics announces positive topline results from the Phase 2b ATTUNE clinical trial of BNC210 in patients with PTSD
ATTUNE trial met its primary endpoint showing BNC210 treatment led to a statistically significant reduction in total PTSD symptom severity at 12 weeks.
Alto Neuroscience Announces Positive Results from Phase 2 Study of ALTO-100 in Post-Traumatic Stress Disorder
Alto Neuroscience Inc. reported results from the post-traumatic stress disorder (PTSD) cohort in its Phase 2a study of ALTO-100, demonstrating clear evidence of efficacy and favorable safety in patients with PTSD.
Peptilogics Reports Positive 180-Day Top-Line Interim Data From Phase 1B Trial of PLG0206 in Patients With Periprosthetic Joint Infection (PJI)
In both patient cohorts followed for six months after PLG0206 treatment, there were no treatment-related serious adverse events and no recurrence was observed in 13 of 14 (93%) treated patients at Day-180 in contrast to reported 180-day success rate of 45%.
Inside Hoxton Farms, the first UK cultured-fat plant and its secret weapon
Hoxton Farms, the London-based biotech developing cultivated animal fat, opens on September 21st its first pilot facility in the center of London to advance research, enable industry scale-up production and develop prototypes with plant-based companies and supermarkets chains.
Rejuveron lands $75m to advance healthy aging portfolio; expands focus in Middle East
Longevity biotech opens strategic Abu Dhabi office as Mubadala Capital joins Series B investment round.
Berlin-based fintech Denario gets acquired by American company Pandadoc to integrate payments workflow
PandaDoc, a leading all-in-one quote-to-cash and contract automation platform, announced the acquisition of German fintech startup Denario, an innovative B2B SaaS company specializing in payment management solutions.
Lindus Health, a UK clinical trials startup backed by Peter Thiel, raises $18M
London startup has the antiquated clinical trials sector in its crosshairs. Backed by Peter Thiel, Lindus Health is a "next-gen" contract research organization that makes it faster and easier to run clinical trials.
Cleerly Wins 2023 Artificial Intelligence Breakthrough Award
Cleerly, the company creating a new standard of care for heart disease, today announced that it has been named “Best Overall AI Solution” in the sixth annual AI Breakthrough Awards program conducted by AI Breakthrough.
Music Financing Startup Duetti Is Trying to Make It Easier for Indie Artists to Sell Their Catalogs
"We're not some financial firm that sits back and is waiting for the income to come in, we're very active in management," says co-founder Lior Tibon.
Duetti closes $32m in funding to democratize music catalog sales, management, & marketing
The music financing platform is bringing investment opportunities to the fastest growing segment of the music industry and giving independent artists the ability to sell their masters. Backed by $32M in funding from Viola Ventures and Viola Credit, Roc Nation, Untitled and Presight Capital, Duetti is uniquely positioned to disrupt the music financing market.
Razor Group closes Series C at $88M at $1.2B valuation, acquires Stryze to consolidate
Razor Group, one of the string of startups that has made a name for itself as a “roll-up” startup — raising big money to acquire and consolidate Amazon (and other marketplace) retailers — is now making a different kind of consolidation play. The Berlin startup has acquired one of its competitors in the aggregator space, Stryze Group, as part of a bid to be “the consolidator of consolidators.”
E-commerce aggregator Una Brands lands $30M just five months after its Series B
Northstar Group, a regional private equity firm, is the sole investor in Una Brands’ latest round, which involves a mix of equity and debt. The company has now raised more than $100 million in total funding since its inception in 2021.
NewAmsterdam Announces Positive Results from Phase 2 Trial of High Cholesterol Treatment
NewAmsterdam Pharma Company announced topline results from a Phase 2 clinical trial evaluating obicetrapib, the company’s oral, low-dose and once-daily cholesteryl ester transfer protein (“CETP”) inhibitor, in combination with ezetimibe as an adjunct to high-intensity statin therapy.
Alto Neuroscience Announces Positive Phase II Results Supporting Precision Psychiatry Platform
On Day 2 of the annual J.P. Morgan Healthcare Conference, Alto’s founder and CEO Amit Etkin, MD, PhD, details the company’s Precision Psychiatry Platform and the safety and efficacy of ALTO-100 in patients with major depressive disorder (MDD).
Spend Management Platform Alaan Raises $4.5M In Latest Funding Round
UAE-based spend management platform Alaan said Monday that it raised $4.5 million in a Pre-Series A funding round led by Presight Capital and Y Combinator with the participation of other angel investors, bringing its total funding to $7 million.
L Catterton Leads New Investment Round in Razor Group
$70 Million Financing Round led by L Catterton to Support Razor’s Leadership as a Global E-Commerce Operator. Razor Group Acquires VALOREO to Advance Global Growth Strategy.
Alloy Therapeutics Raises $42 Million Series D Financing
Following a successful expansion from antibodies into T-cell receptors and genetic medicines, Alloy will broaden its pre-competitive discovery technology and discovery services to enable innovative new therapeutic formats.
French business bank unicorn Qonto buys German competitor Penta
Qonto, the French business banking unicorn, today announced plans to acquire German fintech Penta. The deal is expected to close in the next few weeks, and will help Qonto push hard into Germany — where it hopes to become the market leader.
Time100 Most Influential Companies 2022: Perfect Day
While most animal-milk alternatives have their own unique tastes and textures, Perfect Day has devised a way of “teaching” microflora to produce milk whey protein, resulting in dairy-identical products with no cows involved.
Set to Reach a Billionaire Valuation Soon, Valoreo Raises $80M
Mexico-based startup Valoreo is one surfing the wave of capital inflows for brand aggregators. After raising a $30 million Series A round in July 2021, the company is now securing its Series B, an $80 million round led by the private equity firm L Catterton.
Flush with cash, bamboo-based toilet paper company Cloud Paper makes it rain
Cloud Paper is a sustainable, bamboo-based alternative to toilet paper made from tree-free materials. The company raised a $5 million round from Bezos Expeditions (the personal investment company of Jeff Bezos), Marc Benioff’s TIME Ventures, Presight Capital, Soundwaves and Jeff Wilke.
Velocity bags $20 Mn in Series A round
Fintech startup Velocity has raised $20 million in a Series A round led by Peter Thiel’s Valar Ventures and other investors including Presight Capital, iSeed, Maninder Gulati, Zac Price and Philippe De Mota.
Berlin’s Razor Group raises $125M at a $1B+ valuation
In the latest development, Berlin’s Razor Group has now raised $125 million of equity funding in a Series B round that CEO and co-founder Tushar Ahluwalia said pushes the company past a $1 billion valuation.
UpScalio raises $42.5 million in funding
A consortium of lenders, including freshly minted unicorn OfBusiness, Innoven Capital, and Alteria Capital, have also committed capital to the platform.
Singapore’s Una Brands raises $40m in one of the region’s largest seed rounds
Singapore-based ecommerce aggregator Una Brands said it has raised US$40 million in its seed round of equity and debt financing, marking one of the biggest seed funding rounds in the region.
International VC firm Presight Capital raises $350M second fund
Presight Capital has closed its $350 million second fund only a year and a half after it announced an $80 million first fund.